GS
TMCI icon

Gagnon Securities’s Treace Medical Concepts TMCI Stock Holding History

Gagnon Securities’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1M Sell
3,029,543
-2,172,343
-42% -$5.97M 2.32% 18
2026
Q1 		$6.97M Buy
5,201,886
+2,091,311
+67% +$4.17M 1.61% 21
2025
Q4 		$7.62M Buy
3,110,575
+852,337
+38% +$3.7M 1.55% 23
2025
Q3 		$15.2M Buy
2,258,238
+8,090
+0.4% +$52.8K 3.04% 9
2025
Q2 		$13.2M Buy
2,250,148
+503,612
+29% +$3.28M 2.69% 13
2025
Q1 		$14.7M Sell
1,746,536
-21,397
-1% -$192K 3.22% 7
2024
Q4 		$13.2M Sell
1,767,933
-2,230
-0.1% -$14.9K 2.65% 14
2024
Q3 		$10.3M Buy
1,770,163
+1,286,582
+266% +$8.26M 2.04% 18
2024
Q2 		$3.22M Buy
+483,581
New +$3.91M 0.72% 34

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Gagnon Securities's TMCI Position: Q2 2026 in Review

Gagnon Securities reduced its Treace Medical Concepts (TMCI) stake by 42% in Q2 2026, selling an estimated $5.97M and leaving 3,029,543 shares worth $12.1M. The position accounts for 2.32% of the portfolio, ranked #18.

Gagnon Securities first reported a position in TMCI in Q2 2024 and has held it in 9 quarters since. The position peaked at $15.2M in Q3 2025. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Gagnon Securities held 3,029,543 shares of Treace Medical Concepts worth $12.1M as of Q2 2026.
  • Gagnon Securities sold 2,172,343 Treace Medical Concepts shares in Q2 2026, an estimated $5.97M.
  • Treace Medical Concepts made up 2.32% of Gagnon Securities's portfolio in Q2 2026, its #18 holding.
  • Gagnon Securities first reported a position in Treace Medical Concepts in Q2 2024 and has held it in 9 quarters since.
  • Gagnon Securities's Treace Medical Concepts position peaked at $15.2M in Q3 2025.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Gagnon Securities's 13F filing for Q2 2026, filed 5 Aug 2026.